Signaturefd LLC reduced its stake in Tilray Inc (NASDAQ:TLRY – Free Report) by 3.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 195,735 shares of the company’s stock after selling 6,673 shares during the period. Signaturefd LLC’s holdings in Tilray were worth $450,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of the stock. Clear Street Markets LLC bought a new position in shares of Tilray during the third quarter valued at approximately $25,000. Lake Street Financial LLC bought a new stake in shares of Tilray during the third quarter valued at approximately $28,000. Great Valley Advisor Group Inc. bought a new stake in shares of Tilray during the third quarter valued at approximately $29,000. Stratos Wealth Advisors LLC bought a new stake in shares of Tilray during the third quarter valued at approximately $31,000. Finally, Simplicity Solutions LLC bought a new stake in shares of Tilray during the third quarter valued at approximately $32,000. 9.35% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on the stock. Alliance Global Partners raised their price target on shares of Tilray from $2.25 to $2.75 and gave the company a “neutral” rating in a research report on Friday, April 5th. CIBC reduced their price target on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating for the company in a research report on Wednesday, April 10th. Finally, Canaccord Genuity Group dropped their target price on shares of Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th.
Tilray Stock Performance
Shares of TLRY stock opened at $1.84 on Thursday. The firm’s 50 day moving average is $1.95 and its 200 day moving average is $1.95. Tilray Inc has a 12-month low of $1.50 and a 12-month high of $3.40. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92.
Tilray Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More
- Five stocks we like better than Tilray
- How to Calculate Inflation Rate
- High-Yield Texas Instruments Could Hit New Highs Soon
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Using the MarketBeat Stock Split Calculator
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.